https://www.studioaegle.com/microdosing/guida-al-microdosing/applicazioni-mediche-e-interazioni-farmacologiche/2026-03-27T09:59:01+00:00https://www.studioaegle.com/microdosing/guida-al-microdosing/come-funziona-il-microdosing/2026-03-27T09:58:02+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/compass-pathways/comp360-ptsd/2026-03-27T09:42:29+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/resilient-pharmaceuticals-ex-mapslykos/da-maps-a-resilient-39-anni-per-riportare-lmdma-in-terapia/2026-04-02T13:05:08+00:00https://www.studioaegle.com/ricerca-psichedelica/patologie/disturbi-del-comportamento-alimentare/dca-e-terapia-assistita-da-psichedelici/2026-04-09T14:11:17+00:00https://www.studioaegle.com/microdosing/guida-al-microdosing/effetto-placebo/2026-03-27T09:59:09+00:00https://www.studioaegle.com/ricerca-psichedelica/dimensione-esperienziale/fenomenologia-della-5-meo-dmt/2026-03-27T10:08:42+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/ataibeckley/ibx-210-oud/2026-03-27T09:41:24+00:00https://www.studioaegle.com/ricerca-psichedelica/sostanze/ketamina/2026-04-21T12:02:58+00:00https://www.studioaegle.com/microdosing/guida-al-microdosing/prima-di-iniziare/2026-03-27T09:58:09+00:00https://www.studioaegle.com/microdosing/guida-al-microdosing/protocolli-di-microdosing/2026-03-27T09:59:22+00:00https://www.studioaegle.com/ricerca-psichedelica/patologie/depressione/psichedelici-e-sport/2026-04-09T14:35:05+00:00https://www.studioaegle.com/ricerca-psichedelica/patologie/disturbi-del-comportamento-alimentare/psilocibina-e-binge-eating-disorder-un-primo-segnale/2026-03-27T10:07:13+00:00https://www.studioaegle.com/ricerca-psichedelica/patologie/depressione/psilocibina-vs-escitalopram-nella-depressione-maggiore/2026-03-27T10:01:43+00:00https://www.studioaegle.com/2026-04-21T09:46:22+00:00https://www.studioaegle.com/ricerca-psichedelica/patologie/adhd/2026-03-27T10:01:21+00:00https://www.studioaegle.com/ricerca-psichedelica/sostanze/5-meo-dmt/articoli-scientifici-5-meo-dmt/2026-04-18T09:21:28+00:00https://www.studioaegle.com/microdosing/guida-al-microdosing/benefici-e-rischi-del-microdosing/2026-03-27T09:58:21+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/ataibeckley/bpl-003-trd/2026-03-27T09:40:04+00:00https://www.studioaegle.com/microdosing/guida-al-microdosing/che-cose-il-microdosing/2026-03-27T09:57:45+00:00https://www.studioaegle.com/microdosing/guida-al-microdosing/conclusioni/2026-03-27T09:59:33+00:00https://www.studioaegle.com/ricerca-psichedelica/patologie/depressione/2026-04-09T14:27:27+00:00https://www.studioaegle.com/ricerca-psichedelica/patologie/disturbi-del-comportamento-alimentare/2026-03-27T10:02:01+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/definium-therapeutics/dt-120-gad/2026-04-03T13:51:11+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/definium-therapeutics/dt-402-asd/2026-04-03T14:21:05+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/gh-research/gh001-ppd/2026-04-07T14:46:31+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/gh-research/gh001-trd/2026-04-07T14:23:02+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/gh-research/gh002/2026-04-07T14:40:05+00:00https://www.studioaegle.com/ricerca-psichedelica/meccanismi-e-neurobiologia/gli-psichedelici-e-il-metabolismo-quello-che-succede-fuori-dal-cervello/2026-04-10T12:40:34+00:00https://www.studioaegle.com/ricerca-psichedelica/leggere-uno-studio-psichedelico/glossario/2026-03-27T10:09:51+00:00https://www.studioaegle.com/microdosing/guida-al-microdosing/introduzione/2026-03-27T09:57:34+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/resilient-pharmaceuticals-ex-mapslykos/mdma-at-ptsd/2026-03-31T17:31:02+00:00https://www.studioaegle.com/microdosing/guida-al-microdosing/microdosing-e-ciclo-mestruale/2026-03-27T09:58:50+00:00https://www.studioaegle.com/ricerca-psichedelica/meccanismi-e-neurobiologia/psichedelici-e-microbiota-intestinale-uninterazione-bidirezionale/2026-04-09T14:50:00+00:00https://www.studioaegle.com/ricerca-psichedelica/meccanismi-e-neurobiologia/psichedelici-e-neuroplasticita-il-recettore-trkb/2026-04-10T13:19:17+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/reunion-neuroscience/re-104-ajd/2026-04-07T14:43:13+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/reunion-neuroscience/re245/2026-04-07T09:25:08+00:00https://www.studioaegle.com/ricerca-psichedelica/leggere-uno-studio-psichedelico/scale-di-valutazione/2026-04-07T08:13:07+00:00https://www.studioaegle.com/ricerca-psichedelica/dimensione-esperienziale/stati-alterati-di-coscienza-stati-non-ordinari-di-coscienza-stati-espansi-di-coscienza-non-sono-la-stessa-cosa/2026-04-07T07:40:06+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/ataibeckley/vls-01-trd/2026-03-27T09:40:42+00:00https://www.studioaegle.com/ricerca-psichedelica/sostanze/ibogaina/articoli-scientifici-ibogaina/2026-04-18T09:46:10+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/ataibeckley/bpl-003-dipendenza-da-alcol/2026-04-07T14:49:44+00:00https://www.studioaegle.com/ricerca-psichedelica/patologie/cefalea-a-grappolo-e-psichedelici-i-pazienti-prima-dei-ricercatori/2026-04-14T05:57:08+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/gilgamesh-pharma-abbvie/che-cose-il-blixeprodil/2026-03-27T09:46:19+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/gilgamesh-pharma-abbvie/che-cose-il-bretislocin/2026-03-27T09:46:52+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/reunion-neuroscience/che-cose-luvesilocin/2026-04-07T14:43:56+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/delix-therapeutics/che-cosa-e-jrt/2026-03-27T09:45:26+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/gh-research/come-si-misura-unesperienza-psichedelica-in-meno-di-un-minuto/2026-04-07T15:00:01+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/compass-pathways/comp360-an/2026-03-27T09:42:45+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/compass-pathways/comp360-bd-ii/2026-03-27T09:43:16+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/compass-pathways/comp360-trd/2026-03-27T09:42:09+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/gilgamesh-pharma-abbvie/cosa-cambia-davvero-quando-abbvie-compra-un-psichedelico/2026-03-27T09:47:44+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/delix-therapeutics/dlx-007-dipendenze/2026-03-27T09:45:15+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/definium-therapeutics/dt-120-mdd/2026-04-07T14:50:50+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/ataibeckley/ele-101-md-amanadala-neuro/2026-03-27T09:41:12+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/ataibeckley/emp-01-sad/2026-03-27T09:41:01+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/gh-research/gh001-bdii/2026-04-07T14:46:43+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/gilgamesh-pharma-abbvie/gm-3009-analogo-ibogaina/2026-03-27T09:47:17+00:00https://www.studioaegle.com/microdosing/guida-al-microdosing/2026-03-27T09:57:25+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/resilient-pharmaceuticals-ex-mapslykos/mdma-assisted-psychotherapy/il-protocollo/2026-01-15T15:19:11+00:00https://www.studioaegle.com/ricerca-psichedelica/sostanze/5-meo-dmt/il-trip-da-quindici-minuti-che-mette-in-discussione-tutto-il-modello/2026-04-18T09:29:00+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/mindbio-therapuetics/mb22001-md/2026-03-27T09:48:12+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/resilient-pharmaceuticals-ex-mapslykos/mdma-assisted-psychotherapy/mdma-assisted-psychotherapy-secondo-il-protocollo-maps/2026-04-10T13:42:48+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/mindbio-therapuetics/microdosing-tra-evidenza-e-narrazione/2026-03-27T09:55:15+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/compass-pathways/perche-gli-studi-comp360-sono-cosi-importanti/2026-03-27T09:43:35+00:00https://www.studioaegle.com/microdosing/protocolli-di-microdosing/2026-01-10T17:47:04+00:00https://www.studioaegle.com/regolazione-e-accesso/psichedelici-come-cura-a-che-punto-siamo/2026-04-16T12:34:03+00:00https://www.studioaegle.com/regolazione-e-accesso/psichedelici-in-europa-il-problema-non-e-lapprovazione-e-tutto-quello-che-viene-dopo/2026-03-27T10:11:27+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/gilgamesh-pharma-abbvie/quando-big-pharma-cambia-idea-abbvie-e-la-scommessa-sugli-psichedelici/2026-03-27T09:47:32+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/reunion-neuroscience/re-104-gad/2026-04-07T14:43:36+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/reunion-neuroscience/re-104-ppd/2026-04-07T09:58:56+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/reunion-neuroscience/re104-nella-depressione-post-partum-le-evidenze-cliniche-e-quelle-precliniche-non-dicono-la-stessa-cosa/2026-04-07T09:54:47+00:00https://www.studioaegle.com/ricerca-psichedelica/sostanze/5-meo-dmt/2026-04-18T09:29:00+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/ataibeckley/2026-04-18T11:41:23+00:00https://www.studioaegle.com/psicoterapia-assistita-da-psichedelici/cerchi-di-integrazione-cosa-sono-e-come-funzionano/2026-04-07T07:13:12+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/transcend-therapeutics/che-cosa-e-il-metilone/2026-03-27T09:56:38+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/delix-therapeutics/che-cosa-e-il-tabernanthalog-tbg/2026-03-27T09:45:03+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/delix-therapeutics/che-cosa-e-lo-zalsupindole/2026-03-27T09:44:38+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/definium-therapeutics/2026-04-07T14:51:00+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/delix-therapeutics/delix-therapeutics-la-strada-verso-la-plasticita-senza-trip/2026-03-27T09:45:37+00:00https://www.studioaegle.com/ricerca-psichedelica/dimensione-esperienziale/2026-04-07T14:59:02+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/delix-therapeutics/dlx-001-md/2026-03-27T09:44:50+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/delix-therapeutics/dlx-001-e-il-modello-di-accesso-che-spravato-non-ha-mai-avuto/2026-03-27T09:45:49+00:00https://www.studioaegle.com/regolazione-e-accesso/fda-e-breakthrough-therapy-designation-cosa-significa-davvero/2026-04-14T05:58:07+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/gh-research/2026-04-18T11:44:00+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/gilgamesh-pharma-abbvie/gm-1020-md/2026-03-27T09:46:32+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/gilgamesh-pharma-abbvie/gm-2505-md/2026-03-27T09:47:03+00:00https://www.studioaegle.com/microdosing/il-microdosing-nelladhd-tra-aneddotica-e-trial-controllati/2026-03-27T09:59:47+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/transcend-therapeutics/il-neuroplastogeno-e-i-suoi-segreti-cosa-transcend-non-ha-mostrato/2026-03-27T12:49:04+00:00https://www.studioaegle.com/microdosing/il-problema-del-placebo-e-del-divario-soggettivooggettivo-nel-microdosing/2026-03-27T10:00:11+00:00https://www.studioaegle.com/ricerca-psichedelica/leggere-uno-studio-psichedelico/il-significato-degli-studi-di-fase/2026-03-27T10:09:41+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/resilient-pharmaceuticals-ex-mapslykos/mdma-assisted-psychotherapy/il-sistema-di-valutazione/2026-01-15T15:19:18+00:00https://www.studioaegle.com/psicoterapia-assistita-da-psichedelici/il-terapeuta-deve-aver-fatto-esperienza-con-gli-psichedelici/2026-04-07T07:27:09+00:00https://www.studioaegle.com/psicoterapia-assistita-da-psichedelici/la-psicoterapia-con-la-psilocibina-non-serve/2026-04-18T10:23:11+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/resilient-pharmaceuticals-ex-mapslykos/mdma-e-ptsd-dove-siamo/2026-04-13T07:55:38+00:00https://www.studioaegle.com/ricerca-psichedelica/meccanismi-e-neurobiologia/2026-04-10T13:16:30+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/transcend-therapeutics/metilone-neuroplasticita-senza-esperienza-scalabilita-senza-psicoterapia/2026-03-27T11:34:56+00:00https://www.studioaegle.com/microdosing/microdosing-e-ciclo-mestruale/2026-01-10T17:43:38+00:00https://www.studioaegle.com/microdosing/microdosing-e-sicurezza-cardiovascolare/2026-03-27T10:00:02+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/mindstate-design-labs/2026-04-18T11:44:47+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/resilient-pharmaceuticals-ex-mapslykos/mpva-1/2026-04-02T12:26:06+00:00https://www.studioaegle.com/ricerca-psichedelica/patologie/2026-04-14T05:57:23+00:00https://www.studioaegle.com/regolazione-e-accesso/per-la-prima-volta-lema-assegna-una-designazione-prioritaria-a-un-composto-psichedelico/2026-03-27T10:11:42+00:00https://www.studioaegle.com/ricerca-psichedelica/sostanze/psicoplastogeni/2026-03-27T10:09:00+00:00https://www.studioaegle.com/regolazione-e-accesso/psilocibina-nei-servizi-nhs-inglesi/2026-04-18T10:04:30+00:00https://www.studioaegle.com/regolazione-e-accesso/psilocibina-nella-repubblica-ceca-le-condizioni-duso-del-medicinale-con-psilocibina/2026-03-27T10:11:01+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/studi-di-fase-in-corso/2026-04-07T09:56:26+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/transcend-therapeutics/tsnd-201-ptsd/2026-03-27T11:16:18+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/2026-04-07T10:02:09+00:00https://www.studioaegle.com/chi-sono/2026-04-18T11:53:58+00:00https://www.studioaegle.com/collaborazioni/2026-04-10T09:50:03+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/compass-pathways/2026-04-18T11:41:51+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/compass-pathways/cpsm-compass-psychological-support-model/2026-03-27T09:43:02+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/delix-therapeutics/2026-04-18T11:42:34+00:00https://www.studioaegle.com/psicoterapia-assistita-da-psichedelici/formazione-terapeuti-italia/2026-04-07T06:51:09+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/gilgamesh-pharma-abbvie/2026-04-18T11:42:55+00:00https://www.studioaegle.com/regolazione-e-accesso/guidance-paper-on-psychedelic-therapies-nellambito-del-progetto-di-ricerca-psypal-finanziato-dallue/2026-04-21T09:45:02+00:00https://www.studioaegle.com/ricerca-psichedelica/sostanze/ibogaina/2026-04-13T13:26:44+00:00https://www.studioaegle.com/ricerca-psichedelica/sostanze/ibogaina/ibogaina-lo-stato-investe-le-aziende-spariscono/2026-04-13T13:26:50+00:00https://www.studioaegle.com/psicoterapia-assistita-da-psichedelici/la-neurobiologia-della-finestra-di-plasticita/2026-04-10T13:38:49+00:00https://www.studioaegle.com/psicoterapia-assistita-da-psichedelici/lavorare-con-stati-espansi-di-coscienza-perche-le-regole-cambiano/2026-04-07T07:07:17+00:00https://www.studioaegle.com/ricerca-psichedelica/leggere-uno-studio-psichedelico/2026-04-07T07:49:08+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/resilient-pharmaceuticals-ex-mapslykos/mdma-assisted-psychotherapy/2026-04-10T13:42:20+00:00https://www.studioaegle.com/microdosing/2026-04-11T07:16:01+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/mindbio-therapuetics/2026-04-18T11:44:20+00:00https://www.studioaegle.com/chi-sono/privacy-policy/2026-04-18T11:47:16+00:00https://www.studioaegle.com/psichedelici-e-cure-compassionevoli/2026-04-07T06:25:00+00:00https://www.studioaegle.com/psicoterapia-assistita-da-psichedelici/2026-04-18T10:20:00+00:00https://www.studioaegle.com/regolazione-e-accesso/2026-04-21T09:45:07+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/resilient-pharmaceuticals-ex-mapslykos/2026-04-18T11:45:09+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/reunion-neuroscience/2026-04-18T11:45:31+00:00https://www.studioaegle.com/ricerca-psichedelica/2026-04-18T09:30:01+00:00https://www.studioaegle.com/ricerca-psichedelica/sostanze/2026-04-21T12:03:02+00:00https://www.studioaegle.com/chi-sono/studio-aegle-premium/2026-04-18T11:38:01+00:00https://www.studioaegle.com/psicoterapia-assistita-da-psichedelici/supporto-psicologico-o-psicoterapia-il-campo-psichedelico-non-lo-sa-ancora/2026-03-27T10:10:30+00:00https://www.studioaegle.com/aziende-e-studi-di-fase/transcend-therapeutics/2026-04-18T11:45:54+00:00https://www.studioaegle.com/regolazione-e-accesso/trump-e-gli-psichedelici-lexecutive-order-del-18-aprile-2026/2026-04-21T07:47:15+00:00